Description
Ivosidenib (AG-120) is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1) with potential antineoplastic activity. It specifically inhibits a mutated form of IDH1 in the cytoplasm, preventing the formation of the oncometabolite 2-hydroxyglutarate (2 hG), which may induce cellular differentiation and inhibit cellular proliferation in IDH1-expressing tumor cells.
Molecular Formula
C28H22ClF3N6O3
Smiles
FC1CNCC(C1)N([C@H](C(=O)NC1CC(F)(F)C1)C1CCCCC1Cl)C(=O)[C@@H]1CCC(=O)N1C1CC(CCN1)C#N
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
Ethanol: 100 mg/mL (171.54 mM)H2O: < 1 mg/mL (insoluble or slightly soluble)DMSO: 50 mg/mL (85.77 mM)
Relative Density
1.51 (Predicted)